rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Trimble Inc.

TRMB · Nasdaq

Health CareLife-science toolsAbove a falling average

TRMB stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 40 weeks. It is 1.4% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 40
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$8.7M
Officials’ trades on record
31

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$17.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

31 disclosed lines: House 23, Senate 0, executive 8; 11 people.

WhoDidAmountTraded
April McClain Delaney House: U.S. House ClerkMD06solddependent child$100k–$250k25 Aug 2026filed 9 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k23 Jun 2026filed 22 Aug 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k15 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k14 Apr 2026filed 8 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$100k–$250k18 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k12 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k12 Feb 2026filed 14 May 2026
Arjun Mody Executive branch: Office of Government EthicsSocial Security Administrationsold$1k–$15k30 Jan 2026filed 10 Apr 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k29 Jan 2026filed 2 Feb 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k28 Jan 2026filed 2 Feb 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k12 Jan 2026filed 14 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 6
WhoDidSharesTraded
Kaigham GabrielDirectorsold1,718at $60.004 Aug 2026filed 6 Aug 2026
Mark David SchwartzSenior VP, AECOsold8,442at $67.0116 Apr 2026filed 17 Apr 2026
Mark David SchwartzSenior VP, AECOsold8,283at $67.0116 Apr 2026filed 17 Apr 2026
Robert G. PainterPresident & CEOsold7,500at $66.9414 Apr 2026filed 16 Apr 2026
Robert G. PainterPresident & CEOsold7,500at $70.4510 Mar 2026filed 12 Mar 2026
James Calvin DaltonDirectorsold733at $67.0227 Feb 2026filed 3 Mar 2026
Robert G. PainterPresident & CEOsold7,500at $65.1410 Feb 2026filed 12 Feb 2026
Robert G. PainterPresident & CEOsold7,500at $80.8813 Jan 2026filed 15 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Kenneth B. Bement Company insiderChief Accounting Officer · last 15 Sep 20260 · 0
April McClain Delaney HouseMD06 · last 25 Aug 20260 · 4
Kaigham Gabriel Company insiderDirector · last 4 Aug 20260 · 12
Donald J. Trump Executive branchWhite House Office · last 8 Jul 20262 · 4
Borje Ekholm Company insiderDirector · last 17 Jun 20261 · 0
Johan Wibergh Company insiderDirector · last 17 Jun 20260 · 0
Kara Lynn Sprague Company insiderDirector · last 17 Jun 20260 · 0
Meaghan Lloyd Company insiderDirector · last 17 Jun 20260 · 1
Ronald S. Nersesian Company insiderDirector · last 17 Jun 20260 · 5
Thomas W. Sweet Company insiderDirector · last 17 Jun 20263 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 15 May 20261 · 1
Mark David Schwartz Company insiderSenior VP, AECO · last 16 Apr 20260 · 10

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

Awards6
Total$406K
Latest1 Oct 2026
2021$53K
2023$131K
2025$32K
2026$190K

From its SEC filings

Profit per saleFY 2025 · to 2 Jan 202669.1%
Operating profit marginFY 2025 · to 2 Jan 202616.5%
Free cash flow marginFY 2025 · to 2 Jan 202610.1%
Return on capital employedFY 2025 · to 2 Jan 20267.6%
Cash conversionFY 2025 · to 2 Jan 202691.1%
Debt to equityFY 2025 · to 2 Jan 20260.24×
Research spendFY 2025 · to 2 Jan 202617.6%
Share count trendFY 2025 · to 20 Feb 2026-0.9%
Cash and equivalentsFY 2025 · to 2 Jan 2026$253.4M
Free cash flowFY 2025 · to 2 Jan 2026$360.9M

Analyst forecasts

No analyst forecasts yet.